Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stereotactic Ablative RT”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableLooking for participantsNCT06560697
What this trial is testing

Cervical Boost by Ablative Stereotactic Radiotherapy (SABR) vs Brachytherapy in Patients With Cervical Carcinoma

Who this might be right for
Uterine Cervical Neoplasm
National Institute of Cancerología 84
Not applicableLooking for participantsNCT05679427
What this trial is testing

Ablative Radiosurgery vs Stereotactic RT in 5 Fractions With SIB for Oligometastatic Bone Lesions

Who this might be right for
Oligometastatic Disease
IRCCS San Raffaele 307
Not applicableLooking for participantsNCT05183074
What this trial is testing

MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)

Who this might be right for
Prostate CancerRadiotherapy Side EffectMagnetic Resonance-linac+4 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Early research (Phase 1)Looking for participantsNCT06349837
What this trial is testing

Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors

Who this might be right for
Solid Tumor
Sichuan University 24
Not applicableLooking for participantsNCT05705921
What this trial is testing

Standard Moderately Hypofractionated RT vs. Ultra-hypofractionated Focal Lesion Ablative Microboost in Prostate Cancer

Who this might be right for
Prostate Cancer
The Netherlands Cancer Institute 484